Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
S Ghabri
Observed name:
Salah Ghabri
Institution:
Ministère de la Santé
Observed institutions:
Ministère de la Santé,
Université de Rennes
OpenAlex ID:
A5009504781
EE582 The Principles of the Economic Evaluation and Public Health Committee (CEESP) Doctrine at the French National Authority for Health (HAS)
2022
·
Y Fahfouhi
, M Sion
, et al.
·
Value in Health
·
1
EE318 Review of the Economic Evaluations of Advanced Therapy Medicinal Products (ATMPs) Assessed by the French National Authority for Health (HAS)
2024
·
S Seksik
, E Dautel
, et al.
·
Value in Health
PDF
EE317 What Are the Lessons Learned From the Assessments of Economic Evaluations of Orphan Drugs Submitted by Manufacturers to the French National Authority for Health (HAS) From 2014 to 2024?
2024
·
S Ghabri
, F Simon
·
Value in Health
Les enjeux de l’évaluation thérapeutique des biothérapies : focus sur les médicaments de thérapie innovante
2023
·
Fabienne Bartoli
, Joachim Baba
, et al.
·
Annales des Mines - Réalités industrielles
EE312 Are Methods Used to Generate Utility Values Adequately Included in Technology Assessments for Children and Adolescents? Lessons From HAS Assessments of Manufacturers’ Cost-Utility Analyses
2022
·
Y Fahfouhi
, D Thorrington
, et al.
·
Value in Health
PDF
Show more works
View as search
Works count:
5
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type